Sharemaestro company-news research for Exelixis Inc (EXEL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NASDAQ United States Insufficient evidence

Company news sentiment

EXEL news sentiment

Exelixis Inc

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Full chart Weekly report Factor research Options activity RSS feed
Weighted tone50Neutral is 50
No current sentiment signal 0/100 evidence confidence 0% direct company focus 0 current stories across 0 publishers
Latest weekly closeUSD 54.07week of 7 Aug 2026
Dominant catalystMarket update0/100 classification confidence
News data statusUnavailable0 duplicate stories removed

Current company news

The current company-level signal is not yet measurable

Available headlines do not meet the required combination of freshness, direct relevance and independent source depth. The neutral score is a withheld classification, not a neutral forecast.

Available context

Market context

+2.0% over one week, -4.3% over four weeks, trend active, and materially above fair value.

Why classification is withheld

Company coverage

No current company-specific story carries enough weight to establish a direct signal.

Confidence

Evidence confidence is 0/100, below the threshold for a firm classification.

50/100
Weighted toneNo current sentiment signal
0/100
Evidence confidencethin evidence
0%/100
Company focus0 direct stories
N/A/100
Evidence agreementrequires at least 2 stories

News history

Tone and story flow over 21 days

Daily weighted evidence
No measurable trajectory yet

The chart will begin when a dated headline passes the relevance and freshness controls.

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth0
0 effective stories
Source breadth0
0 independent publishers
Direct relevance0
company-specific evidence share
Freshness0
recency-weighted evidence
Agreement0
requires at least 2 stories
Source independence0
lower publisher concentration

Price context

Sentiment against the 26-week price path

No current news signal

No sufficiently fresh, directly relevant company news is available for a price comparison.

13 Feb 2026: close 43.92, indexed 100.020 Feb 2026: close 43.63, indexed 99.327 Feb 2026: close 44.06, indexed 100.306 Mar 2026: close 41.55, indexed 94.613 Mar 2026: close 41.24, indexed 93.920 Mar 2026: close 41.27, indexed 94.027 Mar 2026: close 41.53, indexed 94.603 Apr 2026: close 43.88, indexed 99.910 Apr 2026: close 44.27, indexed 100.817 Apr 2026: close 44.89, indexed 102.224 Apr 2026: close 44.94, indexed 102.301 May 2026: close 43.68, indexed 99.508 May 2026: close 48.16, indexed 109.715 May 2026: close 50.13, indexed 114.122 May 2026: close 50.15, indexed 114.229 May 2026: close 50.48, indexed 114.905 Jun 2026: close 52.7, indexed 120.012 Jun 2026: close 53.13, indexed 121.019 Jun 2026: close 51.91, indexed 118.226 Jun 2026: close 54.77, indexed 124.703 Jul 2026: close 55.85, indexed 127.210 Jul 2026: close 56.5, indexed 128.617 Jul 2026: close 55.92, indexed 127.324 Jul 2026: close 55.37, indexed 126.131 Jul 2026: close 53.03, indexed 120.707 Aug 2026: close 54.07, indexed 123.1 22 Jun 2026: sentiment 5822 Jun 2026: sentiment 5722 Jun 2026: sentiment 5722 Jun 2026: sentiment 5722 Jun 2026: sentiment 5622 Jun 2026: sentiment 5525 Jun 2026: sentiment 5427 Jun 2026: sentiment 5527 Jun 2026: sentiment 5530 Jun 2026: sentiment 5401 Jul 2026: sentiment 5403 Jul 2026: sentiment 5406 Jul 2026: sentiment 5406 Jul 2026: sentiment 5410 Jul 2026: sentiment 5712 Jul 2026: sentiment 5714 Jul 2026: sentiment 5720 Jul 2026: sentiment 5820 Jul 2026: sentiment 5823 Jul 2026: sentiment 5723 Jul 2026: sentiment 5823 Jul 2026: sentiment 5824 Jul 2026: sentiment 5826 Jul 2026: sentiment 5827 Jul 2026: sentiment 5728 Jul 2026: sentiment 5701 Aug 2026: sentiment 5702 Aug 2026: sentiment 5702 Aug 2026: sentiment 5802 Aug 2026: sentiment 5803 Aug 2026: sentiment 5803 Aug 2026: sentiment 58
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+23.1%latest close 54.07
Sentiment change+0available snapshot window
One-week response+2.0%Price confirming higher
Fair-value position+58.1%Materially above fair value
Insufficient evidence

News subjects

What is shaping the score

Market update

Catalyst structure will appear as classified company evidence builds.

Source mix

Where the evidence comes from

0/100 independence

No current publisher evidence is available.

Recurring subjects

Subjects appearing most often

Current evidence

Topic structure will appear when classified tags are present in the current feed.

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

No matched evidence

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

No qualifying current company evidence

No sufficiently fresh and relevant headline currently passes the evidence rules. Earlier readings remain in the timeline and are not relabelled as a neutral current outlook.

Earlier company news

EXEL news archive

Showing 1-21 of 21 stored headlines

Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.

Aug 03 2026
Investing.com CanadaArchivedPositive tone

Exelixis stock rating maintained at Market Outperform by Citizens

Published
3 Aug 2026 22:49
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Aug 03 2026
TradingViewArchivedPositive tone

Exelixis, Inc. Revenue Breakdown – NASDAQ:EXEL

Published
3 Aug 2026 01:06
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Aug 01 2026
Quiver QuantitativeArchivedPositive tone

Exelixis (EXEL) Slides as Investors Likely Take Profits Ahead of Earnings

Published
1 Aug 2026 07:58
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 28 2026
TradingKeyArchivedPositive tone

Exelixis Inc (EXEL) Income Statement

Published
28 Jul 2026 10:51
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 27 2026
TradingKeyArchivedPositive tone

Exelixis Inc (EXEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Published
27 Jul 2026 12:57
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 26 2026
simplywall.stArchivedPositive tone

Exelixis (EXEL) Stock Still Looks Like A Bargain On Earnings

Published
26 Jul 2026 18:08
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 24 2026
GuruFocusArchivedPositive tone

EXEL Maintained by Morgan Stanley -- Price Target Raised to $53

Published
24 Jul 2026 13:49
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 23 2026
Kalkine MediaArchivedPositive tone

What Happened at Exelixis (NASDAQ:EXEL) Before Results Date?

Published
23 Jul 2026 17:45
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 20 2026
Market sourceArchivedPositive tone

Exelixis (EXEL) Earnings Expected to Grow: Should You Buy?

Published
20 Jul 2026 22:40
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 14 2026
simplywall.stArchivedPositive tone

Exelixis (EXEL) Stock May Be Undervalued Following FDA Review Uncertainty

Published
14 Jul 2026 21:58
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 12 2026
Market sourceArchivedPositive tone

Is Exelixis (EXEL) Expensive After Its Recent Rally Or Still Undervalued?

Published
12 Jul 2026 13:27
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 10 2026
Seeking AlphaArchivedPositive tone

Exelixis: STELLAR-303 Results Mixed, STELLAR-304 Success Likely (NASDAQ:EXEL)

Published
10 Jul 2026 05:17
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 06 2026
simplywall.stArchivedNeutral tone

Zanzalintinib Trial Outcomes And Index Exit Might Change The Case For Investing In Exelixis (EXEL)

Published
6 Jul 2026 12:50
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 03 2026
MT NewswiresArchivedNeutral tone

Exelixis Faces Balanced Risk-Reward Ahead of Key Catalysts, UBS Says

Published
3 Jul 2026 18:01
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jul 01 2026
marketscreener.comArchivedNeutral tone

Exelixis, Inc.(NasdaqGS: EXEL) dropped from Russell 1000 Value-Defensive Index

Published
1 Jul 2026 05:08
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jun 27 2026
simplywall.stArchivedNeutral tone

Is Exelixis (EXEL) Fully Valued On Its STELLAR 303 Trial Update?

Published
27 Jun 2026 21:52
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jun 25 2026
Investing.comArchivedNeutral tone

Truist assumes Exelixis stock coverage with Hold rating on pipeline uncertainty

Published
25 Jun 2026 13:42
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jun 22 2026
Investing.comArchivedNeutral tone

Morgan Stanley reiterates Exelixis stock rating on mixed trial data

Published
22 Jun 2026 19:17
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jun 22 2026
Seeking AlphaArchivedPositive tone

Exelixis falls as final analysis of zanzalintinib phase 3 data disappoints

Published
22 Jun 2026 16:29
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jun 22 2026
Business WireArchivedPositive tone

Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer

Published
22 Jun 2026 14:05
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated
Jun 22 2026
AD HOC NEWSArchivedPositive tone

Exelixis Stock - weekly review and biotech sector context

Published
22 Jun 2026 09:48
Catalyst
Historical snapshot
Coverage
Direct company
Duplicates
1 consolidated

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context